Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2026-01-08 @ 5:54 PM
Study NCT ID:
NCT02891603
Status:
COMPLETED
Last Update Posted:
2025-10-10
First Post:
2016-09-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-18
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-01
First Submit QC Date:
None
Study First Post Date:
2016-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-07-03
Results First Submit QC Date:
None
Results First Post Date:
2023-10-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-10-25
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-09-30
Last Update Post Date:
2025-10-10
Last Update Post Date Type:
ESTIMATED